VIVUS develops and commercializes drug therapies to treat patients with serious medical conditions.
Business Model:
Revenue: $75M
Employees: 51-200
Address: 900 E. Hamilton Avenue
City: Campbell
State: CA
Zip: 95008
Country: US
VIVUS develops and commercializes drug therapies to treat patients with serious medical conditions.
Contact Phone:
+18889984887
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
4/15/1994
Ticker Symbol:
VVUS
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2012 | Angel | $33.6M |
Caxton Advantage Life Sciences Fund, L.P., Euclid SR Partners OrbiMed Advisors LLC Franklin Templeton Investments Quogue Capital LLC |
12/2012 | Series D | $21M |
Zafgen, Inc. |
4/2008 | Unattributed | $30M |
Deerfield Management |
4/1994 | IPO | - | 4/2008 | Post-IPO Debt | 1 | $20M |
Deerfield Deerfield Deerfield Deerfield |
1/1993 | Venture Round | 1 | - |
Frazier Healthcare Partners Frazier Healthcare Partners |
1/1991 | Seed Round | 1 | - |
Domain Associates Domain Associates |
11/2020 | Post-IPO Equity | 5 | $33.6M |
Caxton Advantage Life Sciences Fund EuclidSR Partners Franklin Templeton Investments OrbiMed Quogue Capital Caxton Advantage Life Sciences Fund EuclidSR Partners Franklin Templeton Investments OrbiMed Quogue Capital |
4/1994 | IPO | - | 1/1993 | Venture Round | 1 | - |
Frazier Healthcare Partners Frazier Healthcare Partners |
1/1991 | Seed Round | 1 | - |
Domain Associates Domain Associates |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|